Black Diamond Therapeutic...

NASDAQ: BDTX · Real-Time Price · USD
2.76
-0.03 (-1.08%)
At close: Aug 15, 2025, 3:59 PM
2.77
0.36%
After-hours: Aug 15, 2025, 06:01 PM EDT

Black Diamond Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.68M -82.44M -91.17M -125.6M
Depreciation & Amortization
343K 437K 508K 205K
Stock-Based Compensation
10.63M 9.6M 12.2M 14.04M
Other Working Capital
-4.38M 3.09M -7.67M 5.45M
Other Non-Cash Items
-905K 2M 3.28M 2.01M
Deferred Income Tax
n/a n/a n/a 2.18M
Change in Working Capital
-2.69M 3.69M -9.9M 7.02M
Operating Cash Flow
-62.3M -66.72M -85.08M -100.15M
Capital Expenditures
n/a -33K -192K -2.71M
Cash Acquisitions
n/a n/a 9K 2.7M
Purchase of Investments
-122.88M -61.89M -60.14M -49.51M
Sales Maturities Of Investments
139.75M 78.17M 113.69M 182.83M
Other Investing Acitivies
94K 95K 53.56K -2.7M
Investing Cash Flow
16.97M 16.35M 53.37M 130.61M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
1.05M 82K 177K 729K
Financial Cash Flow
25.55M 71.93M 177K 729K
Net Cash Flow
-19.79M 21.56M -31.54M 31.19M
Free Cash Flow
-62.3M -66.75M -85.27M -102.86M